Taken together, these data suggest that Brk-mediated p38 activation is likely a critical node for mammary epithelial cell pro-survival and relevant to early oncogenic signaling; p38 inhibitors may present an opportunity for therapeutic intervention aimed at long term breast cancer prevention and/or increased sensitivity to chemotherapeutic agents. The gene discussed is MAPK14; the disease is breast carcinoma.